NMPA Approval

Recombinant Human Insulin Injection

Approval Number

国药准字SJ20170011

Registration Date

December 16, 2021

Previous Approval Numbers

S20170011

Drug Information

Generic Name

人胰岛素注射液

Trade Name

优泌林

Dosage Form

注射剂

Strength

3ml:300单位（笔芯）

Drug Type

生物制品

Registration Date

December 16, 2021

Expiry Date

December 15, 2026

Company Address

24 boulevard Vital Bouhot CS 50004 92521 NEUILLY SUR SEINE CEDEX France

Company Address

Zone Industrielle 2 rue du colonel Lilly 67640 Fegersheim,France

Empowering clinical research with data-driven insights and AI-powered tools.

人胰岛素注射液 - NMPA 批准文号 | MedPath